Financial Survey: Fortress Biotech


Fortress Biotech and Vericel Corporation are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, profitability, valuation and risk. Fortress Biotech has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500.



from Biotech News